Clincosm LogoSign in Get a demo

stage iii bladder cancer

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bladder Cancer, Squamous Cell Carcinoma of the Bladder, Stage III Bladder Cancer Trial in Atlanta (3D conformal radiation

Terminated
  • Bladder Cancer
  • +4 more
  • 3D conformal radiation therapy
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Feb 14, 2022

Stage II Breast Cancer, Stage III Breast Cancer, Stage IV Breast Cancer Trial in United States (Behavioral Intervention)

Recruiting
  • Stage II Breast Cancer
  • +22 more
  • Behavioral Intervention
  • Bay City, Michigan
  • +7 more
Sep 29, 2021

Distal Urethral Cancer, Proximal Urethral Cancer, Recurrent Bladder Cancer Trial in United States (afatinib dimaleate,

Recruiting
  • Distal Urethral Cancer
  • +8 more
  • afatinib dimaleate
  • laboratory biomarker analysis
  • Atlanta, Georgia
  • +5 more
Sep 24, 2021

Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in

Completed
Has Results
  • Distal Urethral Cancer
  • +10 more
  • Gemcitabine hydrochloride
  • +3 more
  • Springfield, Missouri
  • +1 more
Sep 17, 2020

Distal Urethral Cancer, Proximal Urethral Cancer, Squamous Cell Carcinoma of the Bladder Trial in Philadelphia (drug, procedure,

Terminated
Has Results
  • Distal Urethral Cancer
  • +5 more
  • gemcitabine hydrochloride
  • +3 more
  • Philadelphia, Pennsylvania
  • +1 more
Jul 26, 2019

Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory

Completed
  • Advanced Malignant Neoplasm
  • +31 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
  • +1 more
Jun 5, 2019

Stage III Bladder Cancer, Stage IV Bladder Cancer Trial in Canada, Israel, United States (Intensity-Modulated Radiation Therapy)

Terminated
Has Results
  • Stage III Bladder Cancer
  • Stage IV Bladder Cancer
  • Intensity-Modulated Radiation Therapy
  • Bakersfield, California
  • +127 more
Nov 16, 2018

Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer

Completed
Has Results
  • Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
  • +6 more
  • sorafenib tosylate
  • laboratory biomarker analysis
  • Toronto, Ontario, Canada
    Princess Margaret Hospital Phase 2 Consortium
Jul 26, 2018

Recurrent Bladder Cancer, Stage III Bladder Cancer, Stage IV Bladder Cancer Trial in Los Angeles (drug, other, genetic)

Terminated
  • Recurrent Bladder Cancer
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
May 10, 2018

Stage I Bladder Cancer, Stage II Bladder Cancer, Stage III Bladder Cancer Trial in United States (dietary supplement, other,

Completed
Has Results
  • Stage I Bladder Cancer
  • +2 more
  • Defined Green Tea Catechin Extract
  • +4 more
  • Birmingham, Alabama
  • +5 more
Oct 17, 2017

Recurrent Bladder Carcinoma, Stage II Bladder Cancer, Stage III Bladder Cancer Trial in Seattle (Cisplatin, Gemcitabine

Completed
Has Results
  • Recurrent Bladder Carcinoma
  • +3 more
  • Seattle, Washington
  • +1 more
Sep 20, 2017

Stage III Bladder Cancer, Stage IV Bladder Cancer, Transitional Cell Carcinoma of the Bladder Trial (doxorubicin HCl,

Completed
  • Stage III Bladder Cancer
  • +2 more
  • doxorubicin hydrochloride
  • +5 more
  • (no location specified)
Aug 1, 2016

Bladder Adenocarcinoma, Bladder Squamous Cell Carcinoma, Bladder Urothelial Carcinoma Trial in New Brunswick (biological,

Terminated
  • Bladder Adenocarcinoma
  • +7 more
  • Recombinant Fowlpox-TRICOM Vaccine
  • +4 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Dec 22, 2014

Adenocarcinoma of the Bladder, Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter Trial

Terminated
Has Results
  • Adenocarcinoma of the Bladder
  • +12 more
  • sorafenib tosylate
  • laboratory biomarker analysis
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
May 20, 2014

Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Metastatic Transitional Cell Cancer of

Terminated
  • Advanced Adult Primary Liver Cancer
  • +13 more
  • gemcitabine hydrochloride
  • +4 more
  • Boston, Massachusetts
  • +2 more
Jul 1, 2013

Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Bladder Cancer, Recurrent Transitional Cell Cancer

Completed
  • Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
  • +9 more
  • San Francisco, California
    UCSF-Mount Zion
Jun 4, 2013

Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,

Completed
  • Advanced Adult Primary Liver Cancer
  • +126 more
  • recombinant interleukin-12
  • ABI-007/carboplatin/trastuzumab
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 27, 2013

Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer Trial in

Completed
  • Distal Urethral Cancer
  • +10 more
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
Jan 23, 2013

Recurrent Bladder Cancer, Stage I Bladder Cancer, Stage II Bladder Cancer Trial in Houston (Ad5CMV-p53 gene)

Completed
  • Recurrent Bladder Cancer
  • +5 more
  • Ad5CMV-p53 gene
  • Houston, Texas
    M D Anderson Cancer Center
Jan 22, 2013